| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235047 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 9 Pages |
Abstract
Immunostaining for DR4, DR5, and TRAIL is frequently observed in the cytoplasm of tumor cells in cervical cancer patients. Absence of TRAIL expression was associated with a higher pathological complete response rate to radiotherapy. DR4, DR5, or TRAIL were not prognostic for disease-specific survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
John H. M.D., Maartje G. B.Sc., Klaske A. ten Hoor, Elisabeth M.D., Ph.D., Henriette J.G. M.D., Ph.D., Jasper J.H. M.D., Harry M.D., Ph.D., Constantijne H. M.D., Ph.D., Steven Ph.D., Elisabeth G.E. M.D., Ph.D., Geertruida H. Ph.D., Ate G.J. M.D., Ph.D.,